PPAR-related metabolic dysregulations, such as obesity and type 2 diabetes, are independent risk factors of carcinogenesis and cancer prognosis predictors [8,9]. This evidence concerns the gene PPARA and obesity due to melanocortin 4 receptor deficiency.